Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors

by Boland, G.M, Cohen, S.
Published 2022

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

by Boland, G.M, Cai, L., Chen, J., Chu, Z., Feng, A., Flaherty, K.T, Frederick, D.T, Geng, S., Georgopoulos, K., Gu, L., Hu, Y., Huang, M., Li, M., Liu, D., Niu, Z., Piris, A., Qi, Y., Shen, C.-H, Shi, Y., Specht, E., Sullivan, R.J, Teng, D., Yoshida, T., Zhang, X., Zheng, B.
Published 2022

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

by Aguet, F., Arniella, M.B, Barzily-Rokni, M., Blackmon, S.M, Blaum, E.M, Boland, G.M, Carrot-Zhang, J., Chen, J.H, Duncan, L.M, Elagina, L., Flaherty, K.T, Frederick, D.T, Freeman, S.S, Gabriel, S., Getz, G., Gonye, A.L.K, Gushterova, I., Ha, G., Hacohen, N., Hammond, M.R, Jiao, Y.J, Kim, J., LaSalle, T.J, Lawrence, D.P, Leshchiner, I., Lin, Z., Livitz, D., Meyerson, M., Ravi, A., Rosebrock, D., Sade-Feldman, M., Sharova, T., Spiro, O.G, Stemmer-Rachamimov, A.O, Stewart, C., Sullivan, R.J, Vitzthum von Eckstaedt, H.C, Wargo, J.A, Yizhak, K.
Published 2022